CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Vaxcyte, Inc. - PCVX CFD

    56.55
    0.25%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.17
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Vaxcyte Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 56.69
    Open* 55.73
    1-Year Change* 29.06%
    Day's Range* 55.73 - 56.99
    52 wk Range 34.11-54.97
    Average Volume (10 days) 573.21K
    Average Volume (3 months) 12.40M
    Market Cap 4.83B
    P/E Ratio -100.00K
    Shares Outstanding 95.15M
    Revenue N/A
    EPS -3.30
    Dividend (Yield %) N/A
    Beta 0.86
    Next Earnings Date Feb 26, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 56.55 -0.18 -0.32% 56.73 57.09 55.65
    Dec 7, 2023 56.69 0.48 0.85% 56.21 57.35 55.27
    Dec 6, 2023 56.19 2.26 4.19% 53.93 56.29 52.85
    Dec 5, 2023 53.62 -0.33 -0.61% 53.95 54.86 53.13
    Dec 4, 2023 54.09 0.97 1.83% 53.12 54.92 52.63
    Dec 1, 2023 53.78 2.82 5.53% 50.96 53.80 50.51
    Nov 30, 2023 51.73 2.05 4.13% 49.68 52.46 49.28
    Nov 29, 2023 49.63 0.21 0.42% 49.42 51.05 49.42
    Nov 28, 2023 50.00 0.84 1.71% 49.16 50.02 48.71
    Nov 27, 2023 50.05 2.10 4.38% 47.95 50.27 47.95
    Nov 24, 2023 49.17 0.71 1.47% 48.46 49.94 48.01
    Nov 22, 2023 48.91 -2.07 -4.06% 50.98 50.99 48.64
    Nov 21, 2023 50.71 1.67 3.41% 49.04 51.65 49.04
    Nov 20, 2023 51.32 0.99 1.97% 50.33 51.90 50.33
    Nov 17, 2023 51.38 2.55 5.22% 48.83 51.66 48.83
    Nov 16, 2023 50.04 0.53 1.07% 49.51 51.04 49.51
    Nov 15, 2023 50.74 2.75 5.73% 47.99 51.66 47.99
    Nov 14, 2023 49.50 0.60 1.23% 48.90 50.83 48.90
    Nov 13, 2023 48.33 1.49 3.18% 46.84 48.76 46.10
    Nov 10, 2023 48.07 0.05 0.10% 48.02 48.38 46.67

    Vaxcyte, Inc. Events

    Time (UTC) Country Event
    Monday, February 26, 2024

    Time (UTC)

    21:00

    Country

    US

    Event

    Q4 2023 Vaxcyte Inc Earnings Release
    Q4 2023 Vaxcyte Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0 0 0 0 0
    Total Operating Expense 232.3 103.67 89.581 54.153 35.533
    Selling/General/Admin. Expenses, Total 73.586 42.735 16.017 8.546 5.388
    Research & Development 135.675 60.935 73.564 45.607 30.145
    Operating Income -232.3 -103.67 -89.581 -54.153 -35.533
    Interest Income (Expense), Net Non-Operating 6.884 2.008 -2.114 0.457 0.87
    Other, Net 1.931 1.585 2.478 3.422 5.178
    Net Income Before Taxes -223.485 -100.077 -89.217 -50.274 -29.485
    Net Income After Taxes -223.485 -100.077 -89.217 -50.274 -29.485
    Net Income Before Extra. Items -223.485 -100.077 -89.217 -50.274 -29.485
    Net Income -223.485 -100.077 -89.217 -50.274 -29.485
    Income Available to Common Excl. Extra. Items -223.485 -100.077 -89.217 -50.274 -29.485
    Income Available to Common Incl. Extra. Items -223.485 -100.077 -89.217 -50.274 -29.485
    Diluted Net Income -223.485 -100.077 -89.217 -50.274 -29.485
    Diluted Weighted Average Shares 64.878 51.9221 29.5458 48.3858 48.3858
    Diluted EPS Excluding Extraordinary Items -3.4447 -1.92744 -3.01962 -1.03902 -0.60937
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -3.08958 -1.92744 -3.00946 -1.03902 -0.60937
    Unusual Expense (Income) 23.039
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0 0 0 0 0
    Total Operating Expense 87.147 71.192 86.617 58.577 47.886
    Selling/General/Admin. Expenses, Total 14.456 26.093 23.334 19.855 16.623
    Research & Development 72.691 45.099 40.244 38.722 31.263
    Operating Income -87.147 -71.192 -86.617 -58.577 -47.886
    Interest Income (Expense), Net Non-Operating 16.344 10.076 7.642 0.503 -1.336
    Other, Net 2.464 0.654 0.925 0.157 0.69
    Net Income Before Taxes -68.339 -60.462 -78.05 -57.917 -48.532
    Net Income After Taxes -68.339 -60.462 -78.05 -57.917 -48.532
    Net Income Before Extra. Items -68.339 -60.462 -78.05 -57.917 -48.532
    Net Income -68.339 -60.462 -78.05 -57.917 -48.532
    Income Available to Common Excl. Extra. Items -68.339 -60.462 -78.05 -57.917 -48.532
    Income Available to Common Incl. Extra. Items -68.339 -60.462 -78.05 -57.917 -48.532
    Diluted Net Income -68.339 -60.462 -78.05 -57.917 -48.532
    Diluted Weighted Average Shares 98.0579 86.2068 79.0122 61.9893 60.8188
    Diluted EPS Excluding Extraordinary Items -0.69693 -0.70136 -0.98782 -0.93431 -0.79798
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.69693 -0.70136 -0.69623 -0.93431 -0.79798
    Unusual Expense (Income) 23.039
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 942.555 256.348 389.004 61.723 66.668
    Cash and Short Term Investments 931.376 245.97 386.2 58.976 66.09
    Cash & Equivalents 834.657 68.985 386.2 58.976 66.09
    Prepaid Expenses 11.179 10.378 2.804 2.747 0.578
    Total Assets 1006.18 324.337 392.826 65.698 70.802
    Property/Plant/Equipment, Total - Net 31.648 35.912 3.272 3.391 3.411
    Property/Plant/Equipment, Total - Gross 37.765 39.46 7.369 6.373 5.162
    Accumulated Depreciation, Total -6.117 -3.548 -4.097 -2.982 -1.751
    Other Long Term Assets, Total 5.426 4.96 0.55 0.584 0.723
    Total Current Liabilities 40.525 28.716 46.861 11.052 6.713
    Accounts Payable 9.795 6.758 29.785 3.376 2.83
    Accrued Expenses 30.73 21.958 17.062 7.657 3.88
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0 0.014 0.019 0.003
    Total Liabilities 52.565 40.319 46.983 11.761 10.72
    Total Long Term Debt 0 0 0 0.45 3.647
    Long Term Debt 0.45 3.647
    Other Liabilities, Total 12.04 11.603 0.122 0.259 0.36
    Total Equity 953.613 284.018 345.843 53.937 60.082
    Redeemable Preferred Stock 160.31 117.81
    Common Stock 0.082 0.056 0.054 0.007 0.006
    Additional Paid-In Capital 1476.02 582.844 544.353 2.967 1.339
    Retained Earnings (Accumulated Deficit) -522.126 -298.641 -198.564 -109.347 -59.073
    Total Liabilities & Shareholders’ Equity 1006.18 324.337 392.826 65.698 70.802
    Total Common Shares Outstanding 79.4707 53.032 51.0716 48.3858 48.3858
    Short Term Investments 96.719 176.985
    Long Term Investments 26.549 27.117
    Other Equity, Total -0.361 -0.241
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 1295.43 1310.32 840.674 942.555 369.759
    Cash and Short Term Investments 1265.68 1287.06 822.038 931.376 362.226
    Cash & Equivalents 545.134 531.033 380.451 834.657 278.401
    Short Term Investments 720.55 756.031 441.587 96.719 83.825
    Prepaid Expenses 29.75 23.253 18.636 11.179 7.533
    Total Assets 1496.06 1502.82 1008.16 1006.18 412.065
    Property/Plant/Equipment, Total - Net 27.764 34.426 34.863 31.648 32.834
    Property/Plant/Equipment, Total - Gross 36.148 42.005 41.691 37.765 38.249
    Accumulated Depreciation, Total -8.384 -7.579 -6.828 -6.117 -5.415
    Long Term Investments 168.564 153.726 127.815 26.549 3.977
    Other Long Term Assets, Total 4.295 4.35 4.811 5.426 5.495
    Total Current Liabilities 85.558 60.216 52.747 40.525 39.309
    Accounts Payable 15.704 16.266 11.615 9.795 5.485
    Accrued Expenses 69.854 43.95 41.132 30.73 33.824
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total
    Total Liabilities 93.341 69.443 63.392 52.565 52.754
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 7.783 9.227 10.645 12.04 13.445
    Total Equity 1402.72 1433.38 944.771 953.613 359.311
    Redeemable Preferred Stock 0
    Common Stock 0.098 0.097 0.084 0.082 0.064
    Additional Paid-In Capital 2148.5 2086.73 1527.23 1476.02 803.98
    Retained Earnings (Accumulated Deficit) -743.591 -650.927 -582.588 -522.126 -444.076
    Other Equity, Total -2.29 -2.521 0.047 -0.361 -0.657
    Total Liabilities & Shareholders’ Equity 1496.06 1502.82 1008.16 1006.18 412.065
    Total Common Shares Outstanding 93.8469 93.8125 80.6408 79.4707 60.5727
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -223.485 -100.077 -89.217 -50.274 -29.485
    Cash From Operating Activities -170.597 -121.393 -46.628 -47.145 -30.466
    Cash From Operating Activities 2.577 1.8 1.405 1.232 1.037
    Non-Cash Items 37.574 13.889 5.914 -2.011 -3.913
    Cash Interest Paid 0.002 0.007 0.007 0.04 0.075
    Changes in Working Capital 12.737 -37.005 35.27 3.908 1.895
    Cash From Investing Activities 74.585 -212.308 -1.105 -1.195 -1.773
    Capital Expenditures -5.848 -6.555 -1.155 -1.195 -1.774
    Other Investing Cash Flow Items, Total 80.433 -205.753 0.05 0 0.001
    Cash From Financing Activities 861.547 17.796 374.87 41.567 62.19
    Issuance (Retirement) of Stock, Net 862.408 17.796 378.299 42.942 62.473
    Issuance (Retirement) of Debt, Net 0 0 -0.061 -0.278 -0.283
    Net Change in Cash 765.672 -316.344 327.224 -7.114 29.951
    Financing Cash Flow Items -0.861 0 -3.368 -1.097 0
    Foreign Exchange Effects 0.137 -0.439 0.087 -0.341 0
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -60.462 -223.485 -145.435 -87.518 -38.986
    Cash From Operating Activities -47.69 -170.597 -105.376 -66.828 -27.702
    Cash From Operating Activities 0.712 2.577 1.875 1.191 0.582
    Non-Cash Items 5.288 37.574 22.147 14.067 6.308
    Cash Interest Paid 0 0.002 0.002 0.002 0
    Changes in Working Capital 6.772 12.737 16.037 5.432 4.394
    Cash From Investing Activities -448.101 74.585 110.537 75.831 49.666
    Capital Expenditures -5.609 -5.848 -4.701 -3.858 -2.92
    Other Investing Cash Flow Items, Total -442.492 80.433 115.238 79.689 52.586
    Cash From Financing Activities 41.562 861.547 204.914 160.897 111.019
    Financing Cash Flow Items -0.727 -0.861 106.763 107.624 107.622
    Issuance (Retirement) of Stock, Net 42.289 862.408 98.151 53.273 3.397
    Issuance (Retirement) of Debt, Net 0
    Foreign Exchange Effects 0.023 0.137 -0.659 -0.712 -0.227
    Net Change in Cash -454.206 765.672 209.416 169.188 132.756
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Fidelity Management & Research Company LLC Investment Advisor 13.6096 12772235 1751381 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.7625 8223374 1702373 2023-06-30 LOW
    RA Capital Management, LP Hedge Fund 8.4086 7891254 600000 2023-06-30 LOW
    Janus Henderson Investors Investment Advisor/Hedge Fund 7.5226 7059751 -67860 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 6.2986 5911023 1434267 2023-06-30 LOW
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 4.7217 4431211 1191937 2023-06-30 LOW
    Capital Research Global Investors Investment Advisor 3.5847 3364127 511121 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.3707 3163312 87296 2023-06-30 LOW
    Fred Alger Management, LLC Investment Advisor/Hedge Fund 2.5267 2371218 1526440 2023-06-30 MED
    T. Rowe Price Associates, Inc. Investment Advisor 2.2909 2149944 2020413 2023-06-30 LOW
    AllianceBernstein L.P. Investment Advisor/Hedge Fund 2.0119 1888106 1804718 2023-06-30 LOW
    Braidwell LP Hedge Fund 1.8353 1722353 402375 2023-06-30 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.7957 1685214 355875 2023-06-30 LOW
    Perceptive Advisors LLC Private Equity 1.72 1614122 444122 2023-06-30 MED
    Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 1.5778 1480747 810663 2023-06-30 LOW
    Jennison Associates LLC Investment Advisor/Hedge Fund 1.5499 1454502 24463 2023-06-30 LOW
    Kynam Capital Management LP Hedge Fund 1.3852 1300000 83216 2023-06-30 MED
    Fidelity Institutional Asset Management Investment Advisor 1.3682 1284001 496290 2023-06-30 LOW
    Millennium Management LLC Hedge Fund 1.2937 1214072 -99570 2023-06-30 HIGH
    Driehaus Capital Management, LLC Investment Advisor/Hedge Fund 1.2679 1189857 575951 2023-06-30 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Vaxcyte, Inc. Company profile

    About Vaxcyte Inc

    Vaxcyte Inc. is a vaccine company, which is focused on developing vaccines designed to prevent or treat common and deadly infectious diseases worldwide. Its cell-free protein synthesis platform enables it to design and produce protein carriers and antigens. Its pipeline includes VAX-24, VAX-XP, VAX-A1 and VAX-PG. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine (PCV). The Company's second PCV candidate, VAX-XP, uses its modular platform and builds on the technical proof of concept established by VAX-24. VAX-A1 is a conjugate vaccine being developed for group A strep infections. Its VAX -PG is being developed as a protein vaccine for the treatment of periodontitis.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Vaxcyte Inc revenues was not reported. Net loss increased 12% to $100.1M. Higher net loss reflects General and administrative - Balancing increase of 49% to $18.5M (expense), Stock-based Compensation in SGA increase of 90% to $6.8M (expense), Stock-based Compensation in R&D increase from $1.9M to $4M (expense).

    Industry: Bio Therapeutic Drugs

    825 Industrial Road, Ste. 300
    SAN CARLOS
    CALIFORNIA 94070
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    BTC/USD

    44,047.25 Price
    -1.270% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Gold

    2,004.85 Price
    -1.180% 1D Chg, %
    Long position overnight fee -0.0198%
    Short position overnight fee 0.0116%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    Oil - Crude

    71.41 Price
    +2.320% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    XRP/USD

    0.68 Price
    +0.260% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading